SEARCH

SEARCH BY CITATION

References

  • 1
    World Health Organization (2000) Obesity: Preventing and Managing the Global Epidemic: Report of a WHO Consultation, i-253. World Health Organization Geneva, Switzerland.
  • 2
    Flegal, K. M., Carroll, M. D., Ogden, C. L., Johnson, CL (2002) Prevalence and trends in obesity among US adults, 1999–2000. JAMA 288: 17231727.
  • 3
    Hu, F. B., Willett, W. C., Li, T., Stampfer, M. J., Colditz, G. A., Manson, JE (2004) Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med. 351: 26942703.
  • 4
    Arterburn, D. E., Crane, P. K., Veenstra, DL (2004) The efficacy and safety of sibutramine for weight loss: a systematic review. Arch Intern Med. 164: 9941003.
  • 5
    Hutton, B., Fergusson, D. (2004) Changes in body weight and serum lipid profile in obese patients treated with orlistat in addition to a hypocaloric diet: a systematic review of randomized clinical trials. Am J Clin Nutr. 80: 14611468.
  • 6
    Padwal, R., Li, S. K., Lau, DC (2004) Long-term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev.: CDfirst.
  • 7
    Anderson, J. W., Vichitbandra, S., Qian, W., Kryscio, RJ (1999) Long-term weight maintenance after an intensive weight-loss program. J Am Coll Nutr. 18: 620627.
  • 8
    Wadden, T. A., Frey, DL (1997) A multicenter evaluation of a proprietary weight loss program for the treatment of marked obesity: a five-year follow-up. Int J Eat Disord. 22: 203212.
  • 9
    Wadden, TA (1993) Treatment of obesity by moderate and severe caloric restriction: results of clinical research trials. Ann Intern Med. 119: 688693.
  • 10
    Sjöström, L., Lindroos, A. K., Peltonen, M., et al (2004) Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 351: 26832693.
  • 11
    Knowler, W. C., Barrett-Connor, E., Fowler, S. E., et al (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 346: 393403.
  • 12
    Tuomilehto, J., Lindstrom, J., Eriksson, J. G., et al (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 344: 13431350.
  • 13
    Tsai, A. G., Wadden, TA (2005) Systematic review: an evaluation of major commercial weight loss programs in the United States. Ann Intern Med. 142: 5666.
  • 14
    Maffiuletti, N. A., Agosti, F., Marinone, P. G., Silvestri, G., Lafortuna, C. L., Sartorio, A. (2005) Changes in body composition, physical performance and cardiovascular risk factors after a 3-week integrated body weight reduction program and after 1-y follow-up in severely obese men and women. Eur J Clin Nutr. 59: 685694.
  • 15
    Sjöström, M., Karlsson, A. B., Kaati, G., Yngve, A., Green, L. W., Bygren, LO (1999) A four week residential program for primary health care patients to control obesity and related heart risk factors: effective application of principles of learning and lifestyle change. Eur J Clin Nutr. 53 (Suppl 2): S72S77.
  • 16
    Bruun, J. M., Helge, J. W., Richelsen, B., Stallknecht, B. (2006) Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects. Am J Physiol Endocrinol Metab. 290: E961E967.
  • 17
    Christiansen, T., Richelsen, B., Bruun, JM (2005) Monocyte chemoattractant protein-1 is produced in isolated adipocytes, associated with adiposity and reduced after weight loss in morbid obese subjects. Int J Obes Relat Metab Disord. 29: 146150.
  • 18
    Becker, W. (2005) New Nordic nutrition recommendations 2004: physical activity as important as good nourishing food. Lakartidningen 102: 27572762.
  • 19
    Anderson, J. W., Konz, E. C., Frederich, R. C., Wood, CL (2001) Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr. 74: 579584.
  • 20
    Torgerson, J. S., Hauptman, J., Boldrin, M. N., Sjöström, L. (2004) XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 27: 155161.
  • 21
    Wadden, T. A., Berkowitz, R. I., Womble, L. G., et al (2005) Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med. 353: 21112120.
  • 22
    Buchwald, H., Avidor, Y., Braunwald, E., et al (2004) Bariatric surgery: a systematic review and meta-analysis. JAMA 292: 17241737.